UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

KMG Chemicals, Inc.

(Exact name of registrant as specified in its charter)

TEXAS		000-29278		75-2640529
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

9555 W. Sam Houston Pkwy S., Houston, Texas Suite 600		77099
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: 713-600-3800

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 2.02		Results of Operations and Financial Condition.

On March 11, 2011, we issued a press release announcing our operating results for our second quarter in fiscal year 2011 (the six month period ended January 31, 2011). A copy of the press release is furnished as Exhibit 99.1 hereto.

Item 9.01		Financial Statements and Exhibits

(d) Exhibits.

99.1		Press Release, dated March 11, 2011

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

KMG Chemicals, Inc.